No Data
No Data
Pacira BioSciences, Inc.'s (NASDAQ:PCRX) 30% Dip In Price Shows Sentiment Is Matching Revenues
Pacira BioSciences, Inc. (NASDAQ:PCRX) shareholders won't be pleased to see that the share price has had a very rough month, dropping 30% and undoing the prior period's positive performance. The dr
Pacira Downgraded at Barclays Following Generic Exparel Approval
This Charter Communications Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Pacira BioSciences Price Target Maintained With a $42.00/Share by Piper Sandler
Pacira BioSciences Price Target Maintained With a $42.00/Share by Piper Sandler
Express News | Piper Sandler Maintains Overweight on Pacira BioSciences, Maintains $42 Price Target
Truist Financial Maintains Pacira BioSciences(PCRX.US) With Buy Rating
Truist Financial analyst Les Sulewski maintains $Pacira BioSciences(PCRX.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 59.5% and a total average return of 9.4% o